Prostatic tissue ablation by injection: A literature review

Journal of Urology

Volumn 172, Issue 1, 2004, Pages 20-26

  Plante, Mark K ^a,b   Folsom, Jeffrey B ^a   Zvara, Peter ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Endoscopy; Ethanol; Injections; Prostatic hyperplasia; Therapeutics

Indexed keywords

ALCOHOL; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT; SOLVENT;

CONFERENCE PAPER; ENDOSCOPY; HUMAN; INJECTION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROSTATITIS; TRANSURETHRAL RESECTION; URETHRA; URINE RETENTION; ANIMAL; CATHETER ABLATION; INTRALESIONAL DRUG ADMINISTRATION; MALE; MICTURITION DISORDER; REVIEW;

ANIMALS; BOTULINUM TOXIN TYPE A; CATHETER ABLATION; ETHANOL; HUMANS; INJECTIONS, INTRALESIONAL; MALE; NEUROMUSCULAR AGENTS; PROSTATIC HYPERPLASIA; SOLVENTS; URINATION DISORDERS;

EID: 3242782578     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000121690.37499.1c     Document Type: Conference Paper

References (74)

1. Chancellor, M. B. and Yoshimura, N.: Voiding function and dysfunction. Physiology and pharmacology of the bladder and urethra. In: Campbell's Urology, 8th ed. Edited by P. C. Walsh, A. B. Retik, E. D. Vaughan, Jr. and A. J. Wein. Philadelphia: W. B. Saunders Co., vol. 2, sect. 23, pp. 829-1734, 2002
2. Townsend, T. M.: Intraprostatic injections. J Urol, 35: 75, 1936
3. Brodie, B. C.: Lectures on diseases of the urinary organs. London, pp. 98-99, 1832
4. Hamilton, J. R.: Some observations on the treatment of acute abscess of the prostate gland pointing to the rectum. Med Press Circ, 2: 613, 1866
5. Maunder, C. F.: On abscess of the prostate; treatment by puncture per rectum. Clin Lect Rep London Hosp, 4: 72, 1867
6. Picard, H.: Note sur les inflammations et abcès de la prostate. Paris, p. 44, 1875
7. Picard, H.: Traité des maladies de la prostate. Paris, p. 53, 1896
8. Stoll, O.: Zur Pathologie und Therapie des acuten Prostata-abscess. Zurich University Thesis, 1877
9. Hoffman, E.: Die Krankheiten der Prostata. In: Klinisches Handbuch der Harn-und Sexual-organe. Leipsic, vol. 3, pp. 1-54, 1894
10. Cano, F. G.: I. Intraprostatic injection of antiseptic substances. Arch Rosales Hosp, 1910
11. Cano, F. G., Townsend, T. M. and Valentine, J. J.: Intravenous and intraprostatic injections of methyl-phenol and normal phenol serum in gonorrhea. Med Red, 91: 715, 1917
12. Talwar, G. L. and Pande, S. K.: Injection treatment of enlarged prostate. Br J Surg, 53: 421, 1966
13. Shipman, J. J. and Akilie, A. N.: Treatment by prostatic injection of acute urinary retention due to prostatic hyperplasia. Br Med J, 2: 418, 1967
14. Lower, W. E. and Johnston, R. L.: Studies in hypertrophy of prostate. 1. Effect of injection of various chemical agents into prostate gland with especial reference to injection of iodine. Trans Am Urol Assoc, pp. 177-179, 1930
15. Riba, L. W., Milligan, B. W. and Queen, F. B.: The effect of intraprostatic injection of 1 and 1.5 per cent aqueous mercurochrome into the prostates of dogs. J Urol, 44: 520, 1940
16. Payr, E.: Presjod (Pregl's solution) in treatment of inoperable prostatic hypertrophy. Munch Med Wochenschr, 83: 381, 1936
17. AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol, 170: 530, 2003
18. Milroy, E. J.: Treatment of the enlarged benign prostate using local injections: a preliminary report. West Indian Med J, 17: 241, 1968
19. Angell, J. C.: Treatment of benign prostatic hyperplasia by phenol injection. Br J Urol, 41: 735, 1969
20. Broughton, A. C. and Smith, P. H.: The significance of perineal pain after injection of the prostate. Br J Urol, 42: 73, 1970
21. Ambiavagar, R., Nambiar, R. and Cohen, Y.: The treatment of benign prostatic obstruction by injections-a clinical trial. Singapore Med J, 16: 196, 1975
22. Sharma, G. D. and Goel, P. P.: Transperineal intraprostatic injection treatment of benign prostatic enlargement. Aust N Z J Surg, 47: 220, 1977
23. Kabra, S. G., Bhargava, M., Jhanwar, J., Sharma, S. K., Pande, S. K. and Chaturvedi, R. P.: Experimental evaluation of injection therapy of enlarged prostate: part II-fate of the fluid injected. Indian J Exp Biol, 15: 768, 1977
24. Bhargava, M., Kabra, S. G., Jhanwar, J., Pande, S. K., Chaturvedi, R. P. and Jain, L. K.: Experimental evaluation of injection therapy of enlarged prostate: Part I-Histopathological changes induced by intrao-prostatic injection of carbolic acid-acetic acid-glycerine mixture. Indian J Exp Biol, 15: 762, 1977
25. Choudhury, A. and Maulik, A. K.: Evaluation of the role of injection therapy for benign prostatic hypertrophy. Br J Urol, 52: 204, 1980
26. Littrup, P. J., Lee, F., Borlaza, G. S., Sacknoff, E. J., Torp-Pedersen, S. and Gray, J. M.: Percutaneous ablation of canine prostate using transrectal ultrasound guidance. Absolute ethanol and Nd:YAG laser. Invest Radiol, 23: 734, 1988
27. Savoca, G., De Stefani, S., Gattuccio, I., Paolinelli, D., Stacul, F. and Belgrano, E.: Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report. Eur Urol, 40: 504, 2001
28. Maria, G., Brisinda, G., Civello, I. M., Bentivoglio, A. R., Sganga, G. and Albanese, A.: Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology, 62: 259, 2003
29. Chiang, P. H., Chuang, Y. C., Huang, C. C. and Chiang, C. P.: Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction. Urology, 61: 797, 2003
30. Plante, M. K., Gross, A. L., Kliment, J., Jr., Kida, M. and Zvara, P.: Intraprostatic ethanol chemoablation via transurethral and transperineal injection. BJU Int, 91: 94, 2003
31. Zvara, P. and Plante, M. K.: Re: Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol, 163: 552, 2000
32. Zvara, P., Karpman, E., Stoppacher, R., Esenler, A. C. and Plante, M. K.: Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology, 54: 411, 1999
33. Larson, T. N. P. P. and Huidobro, C.: Controlled tissue ablation using chemo-gel under ultrasound/MRI guidance. J Endourol, suppl. p. A47, abstract pp. 11-12, 2001
34. Larson, T. N., Huidobro, C. and Palma, P.: Intraprostatic injection of ETOH gel for treatment of BPH: preliminary clinical results. J Endourol, suppl. p. A132, abstract pp. 23-26, 2001
35. McCarthy, J. F.: Recent advances in instrumental urology. J Urol, 33: 303, 1935
36. Mori, K., Okamoto, S. and Akimoto, M.: Intraprostatic ethanol injection prior to transurethral resection of the prostate for prevention of perioperative blood loss. Urology, 45: 171, 1995
37. Harmon, W. J., Barrett, D. M., Qian, J., Lauvetz, R. W., Bostwick, D. G. and Gocken, M.: Transurethral enzymatic ablation of the prostate: canine model. Urology, 48: 229, 1996
38. Goya, N., Ishikawa, N., Ito, F., Ryoji, O., Tokumoto, T., Toma, H. et al: Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol, 162: 383, 1999
39. Adams, J., Zvara, P., Li, S., Bujdak, P., Kliment, J. and Plante, M. K.: Hypertonic saline ablation for benign prostatic hyperplasia: an alternative to ethanol. Presented at annual meeting of New England section of American Urological Association. Le Chateau Frontenac, Quebec City, Quebec, Canada, p. 174, 2000
40. Plante, M. K., Bunnell, M. L., Trotter, S. J., Jackson, T. L., Esenler, A. C. and Zvara, P.: Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with radio-frequency energy and ethanol. Prostate Cancer Prostatic Dis, 5: 183, 2002
41. Gross, A. L., Plante, M. K., Folsom, J. B. and Zvara, P.: Dye diffusion properties of transurethral intraprostatic injection. Unpublished data
42. Plante, M. K., Palmer, J., Martinez-Sagarra, J., Guttierrez, J.s and Gilling, P.: Complications associated with transurethral ethanol ablation of the prostate for the treatment of benign prostatic hyperplasia: a worldwide experience. J Urol, 169: 392, 2003
43. Ditrolio, J., Patel, P., Watson, R. A. and Irwin, R. J., Jr.: Chemoablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction. J Urol, 167: 2100, 2002
44. Ditrolio, J., Patel, P., Watson, R. A. and Irwin, R. I.: An endoscopic injection device: a potential advance in the transurethral treatment of benign prostatic obstruction. BJU Int, 92: 143, 2003
45. Reddington, B.: Retention of urine due to simple prostatic enlargement: treatment by prostatic injection. Nurs Times, 64: 1171, 1968
46. Salleh, H. B.: The treatment of benign prostatomegaly by injection. Aust N Z J Surg, 43: 278, 1973
47. Jhanwar, J., Kabra, S. G., Jhalla, G. S., Chaturvedi, R. P., Sharma, K. K. and Bhargava, M.: Experimental evaluation of injection therapy of enlarged prostate: Part III-effect of carbolic acid-acetic acid-glycerine mixture on vessels. Indian J Exp Biol, 15: 772, 1977
48. Doggweiler, R., Zermann, D. H., Ishigooka, M. and Schmidt, R. A.: Botox-induced prostatic involution. Prostate, 37: 44, 1998
49. Howell, P., Kariampuzha, S., Kipgen, W., Baker, M. Z., Tytle, T. L., Williams, G. R. et al: Non-surgical therapy of primary hyperparathyroidism. J Okla State Med Assoc, 94: 561, 2001
50. De Lima, M. L., Ferreira, U. and Netto, N. R., Jr.: Effect of hyperosmotic substances injected into the prostate of wistar rats. J Endourol, 16: 127, 2002
51. Bartolozzi, C., Lencioni, R., Ricci, P., Paolicchi, A., Rossi, P. and Passariello, R.: Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology, 209: 387, 1998
52. Livraghi, T., Benedini, V., Lazzaroni, S., Meloni, F., Torzilli, G. and Vettori, C.: Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer, 83: 48, 1998
53. Long, C. D., Goldstein, R. E., Hornof, W. J., Feldman, E. C. and Nyland, T. G.: Percutaneous ultrasound-guided chemical parathyroid ablation for treatment of primary hyperparathyroidism in dogs. J Am Vet Med Assoc, 215: 217, 1999
54. Verges, B., Cercueil, J. P., Jacob, D., Vaillant, G. and Brun, J. M.: Treatment of parathyroid adenomas with ethanol injection under ultrasonographic guidance. Ann Chir, 125: 457, 2000
55. Livraghi, T.: Guidelines for treatment of liver cancer. Eur J Ultrasound, 13: 167, 2001
56. Livraghi, T.: Role of percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Dig Dis, 19: 292, 2001
57. Jafri, S. Z., Ellwood, R. A., Amendola, M. A. and Farah, J.: Therapeutic angioinfarction of renal carcinoma: CT follow-up. J Comput Assist Tomogr, 13: 443, 1989
58. Mebust, W. K., Weigel, J. W., Lee, K. R., Cox, G. G., Jewell, W. R. and Krishnan, E. C.: Renal cell carcinoma-angioinfarction. J Urol, 131: 231, 1984
59. Harris, R. G., Constantinou, C. E. and Stanley, T. A.: Extravesical subtrigonal injection of 50 per cent ethanol for detrusor instability. J Urol, 140: 111, 1988
60. Hahn, R. G. and Ekengren, J. C.: Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol, 149: 502, 1993
61. Kim, E. D.: Ethanol injection for the treatment of benign prostatic hyperplasia. Curr Urol Rep, 3: 276, 2002
62. Larson, B. T., Bostwick, D. G., Corica, A. G. and Larson, T. R.: Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications. J Urol, 170: 12, 2003
63. Smith, C. P., Somogyi, G. T. and Chancellor, M. B.: Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Curr Urol Rep, 3: 382, 2002
64. Leippold, T., Reitz, A. and Schurch, B.: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol, 44: 165, 2003
65. O'Conor, V. J. and Ladd, R. L.: Intraprostatic injection. An experimental study-further observation. J Urol, 37: 557, 1937
66. Darson, M. F. and Barrett, D. M.: Transurethral enzyme injection-future management of benign prostatic hyperplasia. Mayo Clin Proc, 73: 908, 1998
67. Schlotthauer, C. F. and Ballman, J. L.: Prostate gland of dog. Cornell Vet, 26: 343, 1936
68. Coffey, D. S. and Walsh, P. C.: Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am, 17: 461, 1990
69. Broderick, G. A., Longhurst, P. A., Juniewicz, P. E., Wein, A. J. and Levin, R. M.: A novel canine model of partial outlet obstruction secondary to prostatic hypertrophy. World J Urol, 12: 245, 1994
70. Bruengger, A., Bartsch, G., Hollinger, B. E., Holly, B. and Rohr, H. P.: Smooth muscle cell of the canine prostate in spontaneous benign hyperplasia, steroid induced hyperplasia and estrogen or tamoxifen treated dogs. J Urol, 130: 1208, 1983
71. Mariotti, A., Donovan, M. P. and Mawhinney, M.: Collagen and cellular proliferation in spontaneous canine benign prostatic hypertrophy. J Urol, 127: 795, 1982
72. Aumuller, G., Funke, P. J., Hahn, A., Hoffbauer, G., Tunn, U. and Neumann, F.: Phenotypic modulation of the canine prostate after long-term treatment with androgens and estrogens. Prostate, 3: 361, 1982
73. Chang, W. Y., Shidaifat, F., Chang, C. J., Kulp, S. K., Sugimoto, Y., Canatan, H. et al: Experimentally-induced prostatic hyperplasia in young beagles: a model to evaluate the chemotherapeutic effects of gossypol. Res Commun Mol Pathol Pharmacol, 92: 341, 1996
74. Bautista, O. M., Kusek, J. W., Nyberg, L. M., McConnell, J. D., Bain, R. P., Miller, G. et al: Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial. Control Clin Trials, 24: 224, 2003